Figure 1

(A) Semaphorin, NRP and VEGF expressions in gliomas measured by quantitative real-time RT–PCR; (B) SEMA3C and SEMA3F expressions in men and women; (C) SEMA3D and VEGF expressions in low- and high-grade gliomas. Results are expressed by $\text{[}{2}^{\text{-Δ}{C}_{\text{t}}}\times 1000\text{]}$, where $\Delta C_{\text{t}}\text{=}{C}_{{\text{t}}_{\text{target}}}\text{-}{C}_{{\text{t}}_{\text{GAPDH}}}$.